Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07859735 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Effects of Impaired Hepatic Function on Velzatinib

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
This study evaluates the pharmacokinetics (PK), safety, and tolerability of velzatinib in participants with mild, moderate, and severe hepatic impairment (HI) and participants with normal hepatic function.
Trial Details
NCT Number NCT07859735
Lead Sponsor GlaxoSmithKline
Conditions
(from sponsor)		 Healthy Participants, Gastrointestinal Neoplasms
Related terms Gastrointestinal Neoplasms
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov